piribedil has been researched along with propranolol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Agnoli, A; Carolei, A; Casacchia, M; Fazio, C; Zamponi, A | 1 |
| Reid, JL | 1 |
| Cramer, H; Kiessling, M; Lindl, T | 1 |
| Cramer, H; Kiessling, M | 1 |
| Martinez-Mir, I; Morales-Olivas, FJ; Rubio, E | 1 |
| Kurako, IuL; Volianskiĭ, VE | 1 |
1 review(s) available for piribedil and propranolol
| Article | Year |
|---|---|
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol | 1984 |
6 other study(ies) available for piribedil and propranolol
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Therapy of Parkinson's disease. Practical criteria of treatment].
Topics: Amantadine; Antiparkinson Agents; Benserazide; Carbidopa; Cyproheptadine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piribedil; Pizotyline; Propranolol | 1976 |
Dopamine supersensitivity in the hypothalamus?
Topics: Animals; Antiparkinson Agents; Body Temperature Regulation; Bromocriptine; Clonidine; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Ergot Alkaloids; Hydroxydopamines; Hypothalamus; Nerve Degeneration; Phenoxybenzamine; Pimozide; Piribedil; Propranolol; Rats; Receptors, Drug; Synaptic Transmission | 1975 |
Cyclic adenosinemonophosphate in cerebrospinal fluid. Effects of theophylline, L-dopa and a dopamine receptor stimulant in rats.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Cyclic AMP; Dose-Response Relationship, Drug; Levodopa; Male; Papaverine; Phentolamine; Piperazines; Piribedil; Propranolol; Rats; Receptors, Drug; Stimulation, Chemical; Time Factors | 1975 |
[Effects of levodopa and piribedil on cyclic AMP levels in cerebrospinal fluid in rats (author's transl)].
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Cyclic AMP; Dopamine; Levodopa; Male; Phentolamine; Piperazines; Piribedil; Propranolol; Rats | 1976 |
The lack of the effect of DA-1 and DA-2 dopamine agonists on the isolated guinea-pig atria.
Topics: Animals; Apomorphine; Benzazepines; Bromocriptine; Domperidone; Electric Stimulation; Female; Fenoldopam; Guinea Pigs; Heart; In Vitro Techniques; Male; Piribedil; Propranolol; Receptors, Dopamine; Vasodilator Agents | 1987 |